Literature DB >> 8719121

Bright light therapy stabilizes the antidepressant effect of partial sleep deprivation.

A Neumeister1, R Goessler, M Lucht, T Kapitany, C Bamas, S Kasper.   

Abstract

Partial sleep deprivation (PSD) results in a pronounced decrease of depressive symptoms in the majority of patients with major depressive disorder. Generally this acute antidepressant effect is not stable, relapse usually occurs after one night of recovery sleep. We therefore studied whether light therapy, beginning in the morning after PSD, is able to prevent the relapse after sleep deprivation, using a controlled, balanced, parallel design. All patients received an antidepressant medication, which was kept constant before and during the study period. Fourteen of 20 patients (70%) showed a reduction of at least 40% in the Hamilton Depression Rating Scale (HDRS) in the morning after PSD and were classified as PSD responders. Responders as well as nonresponders were randomly assigned to receive either bright light (BL/3000 lux) or dim light (DL/100 lux) therapy during the following 6 days after PSD. In the responder group BL therapy prevented significantly (p = 0.005) the relapse after the next night of sleep and prolonged significantly (p = 0.011) the antidepressant effects of PSD up to 7 days. In contrast, patients in the DL condition relapsed after the recovery night and showed no further improvement of the depressive syndrome after 1 week of DL therapy. PSD nonresponders did not benefit from light treatment. These findings indicate that BL therapy might be efficacious to prevent relapse after PSD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8719121     DOI: 10.1016/0006-3223(95)00086-0

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  16 in total

Review 1.  Light therapy for non-seasonal depression.

Authors:  A Tuunainen; D F Kripke; T Endo
Journal:  Cochrane Database Syst Rev       Date:  2004

2.  Transforming the psychiatric inpatient unit from short-term pseudo-asylum care to state-of-the-art treatment setting.

Authors:  David Feifel
Journal:  Psychiatry (Edgmont)       Date:  2008-09

Review 3.  Chronobiological Therapy for Mood Disorders.

Authors:  Sara Dallaspezia; Masahiro Suzuki; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

4.  Sleep deprivation hastens the antidepressant action of fluoxetine.

Authors:  F Benedetti; B Barbini; A Lucca; E Campori; C Colombo; E Smeraldi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

5.  Adjunctive triple chronotherapy (combined total sleep deprivation, sleep phase advance, and bright light therapy) rapidly improves mood and suicidality in suicidal depressed inpatients: an open label pilot study.

Authors:  Gregory L Sahlem; Benjamin Kalivas; James B Fox; Kayla Lamb; Amanda Roper; Emily N Williams; Nolan R Williams; Jeffrey E Korte; Zachary D Zuschlag; Salim El Sabbagh; Constance Guille; Kelly S Barth; Thomas W Uhde; Mark S George; E Baron Short
Journal:  J Psychiatr Res       Date:  2014-09-03       Impact factor: 4.791

6.  Bright light treatment as add-on therapy for depression in 28 adolescents: a randomized trial.

Authors:  Helmut Niederhofer; Kai von Klitzing
Journal:  Prim Care Companion CNS Disord       Date:  2011

7.  Side effects of adjunct light therapy in patients with major depression.

Authors:  M J Müller; E Seifritz; M Hatzinger; U Hemmeter; E Holsboer-Trachsler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

8.  Chronotherapeutic treatments for depression in youth.

Authors:  Stephanie Gest; Martin Holtmann; Sarah Bogen; Carina Schulz; Benjamin Pniewski; Tanja Legenbauer
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-05-17       Impact factor: 4.785

9.  Sleep deprivation and antidepressant treatment.

Authors:  Ulrich Voderholzer
Journal:  Dialogues Clin Neurosci       Date:  2003-12       Impact factor: 5.986

10.  The day-to-day acute effect of wake therapy in patients with major depression using the HAM-D6 as primary outcome measure: results from a randomised controlled trial.

Authors:  Klaus Martiny; Else Refsgaard; Vibeke Lund; Marianne Lunde; Lene Sørensen; Britta Thougaard; Lone Lindberg; Per Bech
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.